BioTelemetry Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- BioTelemetry's estimated revenue is currently $377.3M per year.
- BioTelemetry's estimated revenue per employee is $1565353
- BioTelemetry has 241 Employees.
- BioTelemetry grew their employee count by 22% last year.
- BioTelemetry currently has 195 job openings.
|Andy Broadway||SVP, Sales and Marketing|
|Vince Norlock||Vice President Strategic Business Development|
|Ara Kulidjian||Director of Hardware Engineering|
|Deborah Carfagno||Director, Key Accounts|
|Lianne Cox||Vice President of Operations|
|Michelle Roy||Associate Director of Project Management|
|Ron Way||Senior Vice President- Organizational Strategies|
|Marya Kaszubinski||Associate Director, Project Management|
|Ashlee Verrioli||Director of Site Operations|
|Kevin Disch||Director, IT Infrastructure|
What Is BioTelemetry?
Thank you for visiting the BioTelemetry, Inc.LinkedIn page. The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research. Please visit our subsidiary pages for more information.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Catalyst Capital Advisors LLC decreased its stake in BioTelemetry Inc (NASDAQ:BEAT) by 76.3% during the second quarter, according to its ...
1492 Capital Management LLC lowered its stake in BioTelemetry Inc (NASDAQ:BEAT) by 4.3% during the 2nd quarter, according to its most ...
Research brokerages are projecting BioTelemetry, Inc. (NASDAQ:BEAT) to grow at an accelerated rate over the next 5 years. Wall Street ...